Statements (26)
| Predicate | Object |
|---|---|
| gptkbp:instanceOf |
Person
|
| gptkbp:affiliation |
gptkb:U.S._Food_and_Drug_Administration
|
| gptkbp:awards |
gptkb:Public_Health_Service_Commendation_Medal
FDA_Commissioner’s_Special_Citation FDA’s_Excellence_in_Leadership_Award |
| gptkbp:birthPlace |
gptkb:United_States
|
| gptkbp:children |
Not publicly disclosed
|
| gptkbp:contribution |
Public health policy advocacy
Guidance on vaccine distribution |
| gptkbp:education |
Ph.D.
M.D. |
| https://www.w3.org/2000/01/rdf-schema#label |
Dr. Peter Marks
|
| gptkbp:influences |
Public health decisions
Regulatory science Vaccine policy |
| gptkbp:knownFor |
Biologics regulation
Regulatory oversight of vaccines |
| gptkbp:nationality |
American
|
| gptkbp:positionHeld |
Director_of_the_Center_for_Biologics_Evaluation_and_Research
|
| gptkbp:researchInterest |
Vaccine development
Biologics safety |
| gptkbp:spouse |
Not publicly disclosed
|
| gptkbp:training |
COVID-19_vaccine_approvals
|
| gptkbp:workLocation |
gptkb:Silver_Spring,_Maryland
Public health |
| gptkbp:yearsActive |
2010-present
|